English version Ukrainian version
Last issue Archive Editorial board Instructions to authors Contact us

This site supported by

Ukr. Bioorg. Acta 2020, Vol. 15, N2, 27-31.

Amino acid sulfonamides based on 4-(1-oxo-1H-isochromen-3-yl)benzene-sulfonyl chloride

Anastasiia A. Riabchenko 1, Olga V. Shablykina 1,2*, Serhiy V. Shilin 1,
Svitlana A. Chumachenko
2, Volodymyr P. Khilya 1

1 Taras Shevchenko National University of Kyiv, 60 Volodymyrska St., Kyiv, 01601, Ukraine
tel.: +380-44-239-3342; e-mail: shablykina@ukr.net
2 V. P. Kukhar Institute of Bioorganic Chemistry and Petrochemistry of the NAS of Ukraine, 1 Murmanska St., Kyiv, 02094, Ukraine

The creation of new amino acid derivatives from 4-(1-oxo-1H-isochromen-3-yl)benzenesulfonyl chloride 1 was investigated. The interaction of the sulfonylchloride 1 with amino acid methyl esters (hydrochlorides) in 1,4-dioxane with triethylamine led to the corresponding amino acid sulfonamide derivatives of isocoumarin. The reaction of the sulfonchloride 1 with phenylalanine in the basic water-containing medium was complicated by the lactone system disclosure and led to 2'-carboxydeoxybenzoin ultimately (namely, 2-(2-(4-(N-(1-carboxy-2-phenyl-ethyl)sulfamoyl)phenyl)-2-oxoethyl)benzoic acid). Similar product 2-(2-(4-(N-(1-carboxy-5-methylbuhyl)sulfamoyl)phenyl)-2-oxoethyl)benzoic acid has been obtained by the alkali hydrolysis of methyl ((4-(1-oxo-1H-isochromen-3-yl)phenyl)sulfonyl)leucinate.

sulfonamides, amino acids, 3-phenylisocoumarin, sulfochlorination.

Full text:(PDF, in English)

1. Napolitano, E. Org. Prep. Proced. Int. 1997, 29 (6), 631-664.
2. Barry, R. D. Chem. Rew. 1964, 64 (3), 229-260.
3. Hill, R. A. Prog. Chem. Org. Nat. Prod., 1986, 49, 1-78.
4. Moskvina, V. S.; Shablykina, O. V.; Khilya, V. P. Curr. Top. Med. Chem. 2017, 17 (29), 31993212.
5. O'Brien, E.; Dietrich, D. R Crit. Rev. Toxicol. 2005,35 (1), 33-60.
6. Park, H. B.; Perez, C. E.; Perry, E. K.; Crawford, J. M. Molecules 2016, 21, 824-840.
7. Pal, S.; Pal, M. Isocoumarin, Thiaisocoumarin and Phosphaisocoumarin: Natural Occurrences, Synthetic Approaches and Pharmaceutical Applications; Elsevier, 2018; 216 p.
8. Hepworth, J. D.; Gabbutt, C. D.; Heron, B. M. In Comprehensive Heterocyclic Chemistry, 2nd Ed.; Katritzky, A. R.; Rees, C. W.; and Scriven E. F. V., Eds.; Pergamon, 1996; pp 351-468.
9. Ji Ram, V.; Sethi, A.; Nath, M.; Pratap, R. The Chemistry of Heterocycles: Chemistry of Six to Eight Membered N, O, S, P and Se Heterocycles; Elsevier Science, 2019; 503 p.
10. Seitz, M.; Pluth, M. D.; Raymond, K. N. Inorg. Chem. 2007, 46 (2), 351-353.
11. Cozza, G.; Gianoncelli, A.; Bonvini, P.; Zorzi, E.; Pasquale, R.; Rosolen, A.; Moro, S. ChemMedChem 2011, 6 (12), 2273-2286.
12. Shablykina, .; Ishchenko, V.; Chumachenko, S.; Khilya, V. Visnyk NU. Khimiya 2013, 49 (1), 64-66 (in Ukr.).
13. Raymond, K.; Seitz, M. WO2007/121453 A2, 2007; Chem. Abstr., 2007, XX, XXXXX.
14. Shablykina, .; Chumachenko, S.; Ishchenko, V.; Khilya, V. Visnyk NU. Khimiya 2013, 49 (1), 56-58 (in Ukr.).
15. Kou, X.; Kou, K. G. M. ?-Arylation of Silyl Enol Ethers via Rhodium(III)-Catalyzed CH Functionalization. ACSCatal. 2020, 10 (5), 3103-3109. 
16. Habert, L.; Retailleau, P.; Gillaizeau, I. Org. Biomol. Chem. 2018, 16, 7351-7355.
17. Liu, H.; Yang, Y.; Wu, J.; Wang, X.-N.; Chang, J. Chem. Commun. 2016, 52 (41), 68016804.
18. Zhang, X.; Hou, W.; Zhang-Negrerie, D.; Zhao, K.; Du, Y. Org. Lett. 2015, 17 (21), 5252-5255.
19. Hernandez, M. A.; Powers, J. C.; Glinski, J.; Oleksyszyn, J.; Vijayalakshmi, J.; Meyer, E. F. J. Med. Chem. 1992, 35 (6), 1121-1129.
20. Schoenfeld, R. C.; Bourdet, D. L.; Brameld, K. A.; Chin, E.; de Vicente, J.; Fung, A.; Harris, S. F.; Lee, E. K.; Le Pogam, S.; Leveque, V.; Li, J.; Lui, A. S.-T.; Najera, I.; Rajyaguru, S.; Sangi, M.; Steiner, S.; Talamas, F. X.; Taygerly, J. P.; Zhao, J. J. Med. Chem., 2013, 56 (20), 8163-8182.
21. Weerasinghe, M. S.; Karlson, S. T.; Lu, Y.; Wheeler, K. A. Cryst. GrowthDes. 2016, 16 (4), 1781-1785.

Full-text in PDF